Qiagen stock price jumps nearly 16% as Bloomberg report revives sale talk
New York, January 20, 2026, 12:33 EST — Regular session
- Qiagen shares jumped following reports it’s exploring “strategic options,” possibly including a sale
- Bloomberg reported the diagnostics firm has brought on advisers and is receiving fresh takeover bids
- The company will report its fourth-quarter results on Feb. 4, followed by a conference call on Feb. 5
Qiagen’s shares in the U.S. surged 15.9% to $55.13 on Tuesday after reports surfaced that the molecular diagnostics firm is exploring strategic options, including a potential sale, amid renewed takeover interest. The term often signals major moves like a sale; Qiagen has yet to comment. (Reuters)
This report is significant since Qiagen has been at…
